These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 924898)

  • 21. In vitro activity and serum protein-binding of cefaclor.
    Tally FP; Jacobus NV; Barza M
    J Antimicrob Chemother; 1979 Mar; 5(2):159-65. PubMed ID: 429248
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacological properties and characteristics of cephalexin as compared with other cephalosporins].
    Curci G; Ninni A; Sarappa A; Cristiano P; D'Antonio G
    Arch Monaldi; 1978; 33(1-2):103-16. PubMed ID: 752302
    [No Abstract]   [Full Text] [Related]  

  • 23. Bactericidal activity of cefadroxil, cephalexin, and cephradine in an in vitro pharmacokinetic model.
    Leitner F; Goodhines RA; Buck RE; Price KE
    J Antibiot (Tokyo); 1979 Jul; 32(7):718-26. PubMed ID: 541265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative antibacterial spectrum of cefadroxil.
    Leitner F; McGregor MC; Pursiano TA
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():1-9. PubMed ID: 7142084
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro comparison of cefazolin with other cephalosporins.
    Yeivin R; Meshulam M; Sacks T
    Isr J Med Sci; 1974 Sep; 10(9):1092-5. PubMed ID: 4436031
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro evaluation of cephacetrile, a new cephalosporin antibiotic.
    Neu HC; Winshell EB
    J Antibiot (Tokyo); 1972 Jul; 25(7):400-4. PubMed ID: 4661097
    [No Abstract]   [Full Text] [Related]  

  • 27. 3-Acylthiomethyl cephalosporins.
    Essery JM; Corbin U; Sprancmanis V; Crast LB; Graham RG; Misco PF; Willner D; McGregor DN; Cheney LC
    J Antibiot (Tokyo); 1974 Aug; 27(8):573-8. PubMed ID: 4436142
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative in vitro microbiological activity and stability of cefaclor.
    Gillett AP; Andrews JM; Wise R
    Postgrad Med J; 1979; 55 Suppl 4():9-11. PubMed ID: 44910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antimicrobial activity of a dihydroampicillin and a dihydrocephalexin.
    Hashem AI; Shaban ME; Abdel-Aziz R; Abdel-Nasser G
    Arch Pharm (Weinheim); 1998 Sep; 331(9):294-6. PubMed ID: 9793485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 7-(Alpha-aminophenylacetamido)-3-azidomethyl-3-cephem-4-carboxylic acid.
    Willner D; Holdrege CT; Baker SR; Cheney LC
    J Antibiot (Tokyo); 1972 Jan; 25(1):64-7. PubMed ID: 5013325
    [No Abstract]   [Full Text] [Related]  

  • 31. Cephalexin susceptibility breakpoint for veterinary isolates: Clinical Laboratory Standards Institute revision.
    Papich MG; Lindeman C
    J Vet Diagn Invest; 2018 Jan; 30(1):113-120. PubMed ID: 29145786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of BMY-28100 against common isolates from pediatric infections.
    Scribner RK; Marks MI; Finkhouse BD
    Antimicrob Agents Chemother; 1987 Apr; 31(4):630-1. PubMed ID: 3606067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biophotometric comparison of cephalexin and cephradine against gram-positive bacteria.
    Brumfitt W; Hamilton-Miller JM
    Chemotherapy; 1982; 28(1):40-5. PubMed ID: 7035090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory and clinical studies of cefaclor in Japan.
    Fujii R
    Postgrad Med J; 1979; 55 Suppl 4():88-92. PubMed ID: 398486
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of five oral cephalosporins against anaerobic pathogenic bacteria.
    Shadomy S; Mayhall CG; Apollo E
    J Infect Dis; 1977 Nov; 136(5):697-700. PubMed ID: 915342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in-vitro activity of a new oral carbacephem, LY163892.
    Howard AJ; Dunkin KT
    J Antimicrob Chemother; 1988 Oct; 22(4):445-56. PubMed ID: 3060458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Concept of class in relation to first-generation cephalosporins].
    De Toffoli A; Fantin B; Vechiet D
    Quad Sclavo Diagn; 1984 Jun; 20(2):181-6. PubMed ID: 6441962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro activity of 4 cephalosporins on gram-negative bacteria and Staphylococcus aureus of hospital origin].
    Herrera N; Silva J; Godoy J; Urdanivia R; Becerra S; Jofre M
    Rev Med Chil; 1985 Apr; 113(4):329-33. PubMed ID: 3835642
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of test conditions on the susceptibility of staphylococci in vitro to cephradine, cephaloridine, cephalexin, and cefuroxime.
    Bayston R; Swinden J
    J Clin Pathol; 1981 Feb; 34(2):203-7. PubMed ID: 7229101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.